According to Catalent's latest financial reports the company has $3.68 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-06-30 | $4.61 B | -3.43% |
2022-06-30 | $4.77 B | 11.72% |
2021-06-30 | $4.27 B | 21.91% |
2020-06-30 | $3.50 B | 53.22% |
2019-06-30 | $2.28 B | 110.56% |
2018-06-30 | $1.08 B | 50.2% |
2017-06-30 | $0.72 B | 13.78% |
2016-06-30 | $0.63 B | 0.3% |
2015-06-30 | $0.63 B | -270.52% |
2014-06-30 | $-0.38 B | -9.38% |
2013-06-30 | $-0.42 B | 16.99% |
2012-06-30 | $-0.36 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Supernus Pharmaceuticals
SUPN | $0.92 B | -75.01% | ๐บ๐ธ USA |
Jazz Pharmaceuticals JAZZ | $3.69 B | 0.26% | ๐ฎ๐ช Ireland |
Aerie Pharmaceuticals AERI | -$0.17 B | -104.45% | ๐บ๐ธ USA |
Intercept Pharmaceuticals
ICPT | $71.84 M | -98.05% | ๐บ๐ธ USA |